A recent study published in Aging (Volume 17, Issue 1) on January 6, 2025, sheds light on how inflammation and metabolic health contribute to benign prostatic hyperplasia (BPH), a condition that causes prostate enlargement in aging men. The study, led by Weronika Ratajczak and Olimpia Sipak from Pomeranian Medical University, explores the relationship between inflammation and metabolic syndrome in BPH development, providing fresh insights into the underlying mechanisms of this common disorder.
BPH affects millions of men as they age, causing symptoms like difficult and painful urination. While age and hormonal changes are established contributors, the exact causes of prostate enlargement remain poorly understood. This study suggests that inflammatory markers, particularly those derived from lipids, may play a significant role in BPH, especially in men with metabolic syndrome—a group of conditions including obesity, high blood sugar, and high cholesterol.
The research team analyzed blood samples from 219 men, including 144 with BPH and 75 without, to measure markers of inflammation and oxidative stress. The results revealed that men with BPH had significantly elevated levels of pro-inflammatory molecules, such as 12S-HETE and 5-HETE, while showing lower levels of anti-inflammatory substances like lipoxin A4. This imbalance was more pronounced in men with both BPH and metabolic syndrome, suggesting a link between metabolic dysfunction and the progression of prostate enlargement.
“These findings add to the growing body of evidence connecting inflammation to the development of prostate diseases, including BPH and prostate cancer,” the researchers noted.
The study also highlights that metabolic dysfunction and chronic inflammation may not only contribute to the onset of BPH but also intensify its severity. Therefore, managing metabolic health could be key to reducing the risk of prostate enlargement.
Future research may explore whether anti-inflammatory treatments or lifestyle interventions—such as better diet, weight management, and regular exercise—can help slow BPH progression or alleviate its symptoms.
Related topics:
Fertility Treatment Access and Policies Across the EU: A Complex Landscape
Femasys Gains UK Approval for Female Infertility and Diagnostic Devices
